ID

32688

Description

Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data:  Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis

Keywords

Versions (1)
  1. 11/12/18 11/12/18 -
Copyright Holder

GSK group of companies

Uploaded on

November 12, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Estimation of Dose Proportionality of Darapladib - 107038

English

Investigational Product (Dose)

1 forms  
Investigational Product
Description

Investigational Product

Date of dose
Description

Date of dose

Data type

date

Time of dose
Description

Time of dose

Data type

time

Dose
Description

Dose

Data type

text

Back to the top of the page

Similar models

Investigational Product (Dose)

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Investigational Product
Date of dose
Item
Date of dose
date
Time of dose
Item
Time of dose
time
Item
Dose
text
Dose
Code List
Dose
CL Item
40 MG (1)
CL Item
80 MG (2)
CL Item
160 MG (3)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial